| ID | Sequence | Length | GC content |
|---|---|---|---|
| GGGGAACACACUCGCUGCAGCCCCGCCUGGGCCACGGCACCCUCGAGCG… | 1905 nt | 0.6472 | |
| ACUUCCGGAAGCGGCGGCGCUCGGGAGGAAGUGCCGAUCGGCUGCUGGG… | 1918 nt | 0.6439 | |
| ACUUCCGGAAGCGGCGGCGCUCGGGAGGAAGUGCCGAUCGGCUGCUGGG… | 1910 nt | 0.6466 | |
| ACUUCCGGAAGCGGCGGCGCUCGGGAGGAAGUGCCGAUCGGCUGCUGGG… | 1997 nt | 0.6460 | |
| ACUUCCGGAAGCGGCGGCGCUCGGGAGGAAGUGCCGAUCGGCUGCUGGG… | 1867 nt | 0.6411 |
Enables DNA-binding transcription repressor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Involved in negative regulation of epidermal growth factor-activated receptor activity and negative regulation of transcription by RNA polymerase II. Located in nucleoplasm and plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
A review of RNA-Seq studies in post-mortem human brains notes that the ZGPAT was identified as a differentially expressed gene in the hippocampus, representing a shared neuronal function-associated molecular change in addiction when comparing cocaine-addicted and alcoholic brains to controls [Wu et al. DOI:10.1111/Pcn.12550].